Alexander B. Olawaiye

Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?

K. Tucker, A. Staley, P. Gehrig, 2020, Gynecologic oncology.

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.

E. Kohn, Su-Chun Cheng, G. Shapiro, 2020, The Lancet. Oncology.